Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on March 11, 2008
JNCI Journal of the National Cancer Institute 2008 100(6):444-445; doi:10.1093/jnci/djn017
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
100/6/444    most recent
djn017v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Zhang, S. M.
Right arrow Articles by Ridker, P. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zhang, S. M.
Right arrow Articles by Ridker, P. M.
Related Collections
Right arrowRelated Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press.

CORRESPONDENCE

Response: Re: C-Reactive Protein and Risk of Breast Cancer

Shumin M. Zhang, Paul M. Ridker

Affiliations of authors: Division of Preventive Medicine (SMZ, PMR), Center for Cardiovascular Disease Prevention (PMR), and Donald W. Reynolds Center for Cardiovascular Research (PMR), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Epidemiology, Harvard School of Public Health, Boston, MA (PMR)

Correspondence to: Shumin M. Zhang, MD, ScD, Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, 900 Commonwealth Ave East, Boston, MA 02215 (e-mail: shumin.zhang@channing.harvard.edu).

The first 10% of the full text of this article appears below.

We thank Zeleniuch-Jacquotte et al. for their interest in our paper, which showed no statistically significant positive association between baseline plasma C-reactive protein (CRP) levels and breast cancer risk in a prospective analysis involving 892 case patients among 27919 women followed-up for an average of 10 years in the Women's Health Study. They reported . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Correspondence

Re: C-Reactive Protein and Risk of Breast Cancer
Anne Zeleniuch-Jacquotte, Yian Gu, Peter F. Bruning, Johannes M.G. Bonfrer, Karen L. Koenig, Alan A. Arslan, Paolo Toniolo, and Roy E. Shore
J Natl Cancer Inst 2008 100: 443-444. [Extract] [Full Text] [PDF]